Then, of course, there’s the M3 CSL, the best version of everyone’s favourite 3 Series. It was notable even in an ...

CSL Ltd (ASX: CSL) shares have had a rough run this year. The biotech giant ended last week at $212.47, meaning its share price has tumbled about 28% over the past year. For a company long viewed as ...

A rare 2023 BMW M4 CSL with only 1,600 miles is up for sale on Bring a Trailer. This lightweight, high-performance coupe looks almost new and demands attention. The Ultimate Driving Machine never ...

The exit delivers a 3.5x return CSL has grown around 20% annually ECI first invested in CSL in 2020 ECI Partners has exited CSL, a critical IoT connectivity business, into a continuation fund, ...

CSL's shares have declined over 25% this year due to slower margin recovery, tariff concerns, and Seqirus demerger uncertainty, challenging investor confidence. Despite these issues, analysts like ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Australian biotechnology ...

Gift 5 articles to anyone you choose each month when you subscribe. CSL chief financial officer Joy Linton retired on Tuesday. That’s the big Australian biotech trying to change the story. Something ...

Akshay Kumar About To Hit 800 Crore Total! Interestingly, currently, with four releases in the year, Akshay Kumar has earned a total of 749 crore globally. Jolly LLB 3 is swiftly leading the actor ...

The company had told staff the offer in the proposed CSL Behring Agreement covering two Melbourne sites was more beneficial than the CSL Seqirus Agreement, which was finalised earlier this year. But ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An announcement from CSL ( (AU:CSL)) is ...

CSL has partnered with Dutch biotech VarmX to co-develop VMX-C001, a potential first-in-class treatment to restore blood coagulation in patients on FXa inhibitors. The agreement includes an upfront ...

Full funding of VMX-C001 Phase 3 trial, late-stage product development, manufacturing and pre-launch activities VarmX shareholders to receive initial $117m upfront and further potential milestone ...